0.0100
+0.0005
+(5.26%)
At close: January 31 at 3:00:00 PM EST
Breakdown
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Total Assets
31.3830
499.0390
811.1660
3,078.9610
Total Liabilities Net Minority Interest
2,511.3630
2,516.3280
2,443.4770
1,273.0460
Total Equity Gross Minority Interest
-2,479.9800
-2,017.2890
-1,632.3110
1,805.9150
Total Capitalization
-2,479.9800
-2,017.2890
-1,632.3110
1,805.9150
Common Stock Equity
-2,479.9800
-2,017.2890
-1,632.3110
1,805.9150
Net Tangible Assets
-2,479.9800
-2,017.2890
-1,632.3110
1,805.9150
Working Capital
-2,479.9800
-2,292.0200
-2,245.1880
317.8010
Invested Capital
-1,184.8730
-673.7050
126.3910
2,677.8110
Tangible Book Value
-2,479.9800
-2,017.2890
-1,632.3110
1,805.9150
Total Debt
1,295.1070
1,343.5840
1,758.7020
871.8960
Net Debt
1,268.6910
1,213.8880
1,641.1870
--
Share Issued
31,111.3520
22,611.3520
1,257.9270
1,238.7940
Ordinary Shares Number
31,111.3520
22,611.3520
1,257.9270
1,238.7940
8/31/2021 - 9/4/2007
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YECO EV Biologics, Inc.
0.1010
0.00%
GBLX GB Sciences, Inc.
0.0040
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
1BT.F Enlivex Therapeutics Ltd.
1.0500
0.00%
PI3.DU Gubra AS
88.40
-0.23%
GYX.F Futura Medical plc
0.1750
-50.00%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1AEA.F argenx SE
635.00
+2.42%
CVAC.VI CureVac N.V.
3.6780
-2.13%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4690
+1.52%